87 related articles for article (PubMed ID: 19249990)
1. Generation and characterization of monoclonal antibodies against prostate-specific antigen.
Karuppaiya A; Cheah SH; Mohd S; Kamal WH; Zulkifli MH
Hybridoma (Larchmt); 2009 Apr; 28(2):133-7. PubMed ID: 19249990
[TBL] [Abstract][Full Text] [Related]
2. Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization.
Leinonen J; Niemelä P; Lövgren J; Bocchi L; Pettersson K; Nevanlinna H; Stenman UH
J Immunol Methods; 2004 Jun; 289(1-2):157-67. PubMed ID: 15251421
[TBL] [Abstract][Full Text] [Related]
3. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient.
Abdel-wahab ZA; Gillanders WE; Darrow TL; Seigler HF
Hum Antibodies Hybridomas; 1992 Jan; 3(1):32-9. PubMed ID: 1576321
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of a high-affinity monoclonal antibody for MUC1 measurement in breast cancer.
Hamid SS; Cheah SH
Hybridoma (Larchmt); 2011 Apr; 30(2):137-43. PubMed ID: 21529286
[TBL] [Abstract][Full Text] [Related]
5. Production of monoclonal and polyclonal antibodies against prostate-specific antigen, a prostate cancer serum marker.
Chou SF; Chen CY
Hybrid Hybridomics; 2004 Feb; 23(1):73-7. PubMed ID: 15000852
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of a panel of monoclonal antibodies specific for human fibroblast growth factor receptor 4 (FGFR4).
Chen C; Patel S; Corisdeo S; Liu X; Micolochick H; Xue J; Yang Q; Lei Y; Wang B; Soltis D
Hybridoma (Larchmt); 2005 Jun; 24(3):152-9. PubMed ID: 15943563
[TBL] [Abstract][Full Text] [Related]
7. [Preparation and identification of monoclonal antibodies against Type M/N and Glycophorin A/B].
Chen Q; Cao H; Zhang HY; Gao XF; Wang F; Li HD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):556-8. PubMed ID: 17553354
[TBL] [Abstract][Full Text] [Related]
8. Private idiotypes located on light and heavy chains of human myeloma proteins characterized by monoclonal antibodies.
Hajighasemi F; Gharagozlou S; Ghods R; Khoshnoodi J; Shokri F
Hybridoma (Larchmt); 2006 Dec; 25(6):329-35. PubMed ID: 17203994
[TBL] [Abstract][Full Text] [Related]
9. Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassay.
Wang TJ; Linton HJ; Payne J; Rittenhouse HG; Chan DW; Partin AW; Wolfert RL; Kuus-Reichel K
Hybridoma; 1999 Dec; 18(6):535-41. PubMed ID: 10626683
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting production of antibodies to prostate antigens by in vitro-primed human splenocytes.
Lu EW; Bustria AT; Royston I; Brams P
Hybridoma; 1993 Aug; 12(4):381-9. PubMed ID: 7503938
[TBL] [Abstract][Full Text] [Related]
11. Generation of murine monoclonal antibodies in serum-free medium.
Liu RS; Ta D; Payne J; Coccia M; Kuus-Reichel K
Hybridoma; 1998 Feb; 17(1):69-72. PubMed ID: 9523240
[TBL] [Abstract][Full Text] [Related]
12. Screening and characterization of monoclonal antibodies to the surface antigens of Listeria monocytogenes serotype 4b.
Lin M; Armstrong S; Ronholm J; Dan H; Auclair ME; Zhang Z; Cao X
J Appl Microbiol; 2009 May; 106(5):1705-14. PubMed ID: 19226395
[TBL] [Abstract][Full Text] [Related]
13. Development of new prostate specific monoclonal antibodies.
Lampe MI; Molkenboer-Kuenen JD; Oosterwijk E
Prostate; 2004 Feb; 58(3):225-31. PubMed ID: 14743460
[TBL] [Abstract][Full Text] [Related]
14. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
[TBL] [Abstract][Full Text] [Related]
15. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
16. Preparation and identification of monoclonal antibody against abrin-a.
Li XB; Yang W; Zhang Y; Zhang ZG; Kong T; Li DN; Tang JJ; Liu L; Liu GW; Wang Z
J Agric Food Chem; 2011 Sep; 59(18):9796-9. PubMed ID: 21870856
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of monoclonal antibody against human serum albumin.
Omidfar K; Kashanian S; Paknejad M; Kashanian S; Larijani B; Roshanfekr H
Hybridoma (Larchmt); 2007 Aug; 26(4):217-22. PubMed ID: 17725383
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of monoclonal antibodies against 17alpha-hydroxyprogesterone.
Chong H; Cheah SH; Ragavan M; Johgalingam VT
Hybridoma (Larchmt); 2006 Feb; 25(1):34-40. PubMed ID: 16475880
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein.
Corey E; Buhler KR; Vessella RL
Urology; 1997 Oct; 50(4):567-71; discussion 571-2. PubMed ID: 9338733
[TBL] [Abstract][Full Text] [Related]
20. Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer.
Katzenwadel A; Schleer H; Gierschner D; Wetterauer U; Elsässer-Beile U
Anticancer Res; 2000; 20(3A):1551-5. PubMed ID: 10928069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
